No image in the catalogue
GLISTROMA
Therapy Area: Glioblastoma,Astrocytoma; TEMOZOLAMIDE 100 mg. CAP.: 100 mg.; TEMOZOLAMIDE 20 mg. CAP.: 20 mg.; TEMOZOLAMIDE 250 mg. CAP.: 250 mg.
About this product
Therapy Area: Glioblastoma,Astrocytoma TEMOZOLAMIDE 100 mg. CAP.: 100 mg. TEMOZOLAMIDE 20 mg. CAP.: 20 mg. TEMOZOLAMIDE 250 mg. CAP.: 250 mg.
1 specification table for this product
Sign in with a free buyer account to see the complete tables, every construction and grade.
No certificates on file for Alkem Laboratories Ltd.
Alkem Laboratories Ltd
- Location
- India
- US shipments
- 36 to 2 buyers since Jan 2, 2026
Contact the supplier
What are you looking for from Alkem Laboratories Ltd?
Prefer a form? Submit an RFQ